Citius Pharmaceuticals (CTXR) Misses Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts CTXR Hot Sheet
Join SI Premium – FREE
Citius Pharmaceuticals (NASDAQ: CTXR) reported Q2 EPS of ($0.11).
For earnings history and earnings-related data on Citius Pharmaceuticals (CTXR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Profusa reports Q2 2026 loss, advances G3 Vision Labs deal
- Nlight (LASR) Reiterated at Buy by Stifel: Sell-off is a 'Buying Opportunity'
Create E-mail Alert Related Categories
EarningsRelated Entities
Citi, Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
